Main > ONCOLOGY (**) > Skin Cancer>Merkel Cell C.>MET *** > Treatment > DE. M. AveluMAb Inj.

---

DE. M. AveluMAb Inj.'s subsections
(*) EU Approval Date: 2017. 09.21.
(*) JP Approval Date: 2017. 09.27.
(*) USA Approval Date: 2017. 03.23.
Company
Company Partner
Human Anti-PD-L1 AB
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.29.
TradeMark
TradeMark Web-Site

DE. M. AveluMAb Inj.'s products
This section has no products